Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesDigital X-RayDEXA receives major boost for osteoporosis screeningGreater emphasis looks set to be put on the use of dual-energy x-ray absorptiometry (DEXA) for osteoporosis screening.MRIML model using CCTA, MRI data predicts MACE in cardiac patientsClinical NewsPatient death prompts RCR to act on gastric bandsMRIGenetic testing, risk assessment tied to more breast MRI uptakeMolecular ImagingPET scans can reduce unnecessary lymph node procedures